ArticleSmall (Weinheim an der Bergstrasse, Germany)2014

Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors.

Minati Satpathy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.